Article
Enantioselective disposition of lansoprazole and rabeprazole in human plasma.
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan - 1 Jun 2006
Miura Masatomo
Abstract excerpt
Lansoprazole is extensively metabolized by CYP2C19 and CYP3A4 in the liver, whereas rabeprazole is primarily converted non-enzymatically to rabeprazole-thioether, with only some being oxidized by CYP2C19 and CYP3A4. Lansoprazole and rabeprazole possess asymmetric sulfur in their chemical structure and have typically been used clinically as a racemic mixture. This article reviews the pharmacokinetic differences...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
